Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02723266 · ClinicalTrials.gov registry record · NA
Supporting American Indian/Alaska Native Mothers and Daughters in Reducing Gestational Diabetes Risk
A NA study of Gestational Diabetes Mellitus, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 398
- Enrollment target
- 1
- Study location
NCT02723266: Completed NA study of Gestational Diabetes Mellitus, sponsored by University of Pittsburgh.
NCT02723266 is a NA study of Gestational Diabetes Mellitus that has completed, run by University of Pittsburgh. The registered enrollment target is 398 participants, roughly in line with the 394-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02723266, a NA study of Gestational Diabetes Mellitus, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 398 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to modify an existing Reproductive Health intervention for adolescents with diabetes for Gestational Diabetes and make it culturally appropriate American Indian/Alaska Native adolescents. The intervention will then be evaluated for effectiveness in AI/AN female teens at risk for GDM.
Primary Outcome
Family-Planning Vigilance Behavior are defined as using effective family planning/abstinence, seeking PC, and initiating discussion with health care professionals . "Effective family planning behaviors" is a weight summary of the teen's most frequently used contraception. Weights will be derived using the annual failure rates for methods of contraception reported in Trussell's algorithm. Rates are transformed into probabilities of failure (0 to 1), 0 = no failure. Overall effectiveness of contra
Conditions Studied
Interventions
- BEHAVIORAL STOPPING-GDM
Study Locations (1)
Oklahoma
- Indian Health Resource Center of Tulsa - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2018-03-16 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
What the finished NCT02723266 record still lists
NCT02723266 is an interventional study that assigns participants to a tested intervention. The registered 398 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 394-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target.
The record links to 1 condition, with Gestational Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which STOPPING-GDM is the first listed.
NCT02723266 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT02723266 about?
NCT02723266 is a clinical study titled "Supporting American Indian/Alaska Native Mothers and Daughters in Reducing Gestational Diabetes Risk". The purpose of this study is to modify an existing Reproductive Health intervention for adolescents with diabetes for Gestational Diabetes and make it culturally appropriate American Indian/Alaska Native adolescents. The intervention will then be evaluated for effectiveness in AI/AN female teens at ...
What is the current status of trial NCT02723266?
This trial is currently completed. It is a NA study. The enrollment target is 398 participants. The study started on 2018-03-16. Estimated completion is 2019-09-30.
What conditions does trial NCT02723266 study?
This clinical trial studies the following conditions: Gestational Diabetes Mellitus.
What interventions are being tested in trial NCT02723266?
The interventions under investigation include: STOPPING-GDM (BEHAVIORAL).
Who is sponsoring clinical trial NCT02723266?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02723266 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02723266's enrollment target sits among peer trials
398 5th of 16 higher than 12 of 16 other Gestational Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
RECRUITING · NA
-
A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus
ACTIVE NOT RECRUITING · NA
-
Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes
COMPLETED · NA
-
Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids
COMPLETED · NA
-
Balance After Baby Intervention for Women With Recent Gestational Diabetes
COMPLETED · NA
-
Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI